Mahatme Sandesh sold VOR

December 5, 2025 · Form 4 insider transaction

Mahatme Sandesh sold 694,137 shares of Vor Biopharma Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as disposition to the issuer and disclosed on an SEC Form 4, filed 4 days after the transaction.

Direction
Disposed (sell-side)
Shares
694,137
Price
$0.00
Total value
N/A
RoleOfficer, Director
SecurityCommon Stock
Transaction codeD: Disposition to the issuer
Transaction dateDecember 5, 2025
Filing dateDecember 9, 2025
Shares owned after0
OwnershipDirect
10b5-1 planNo
AmendedNo

Footnotes

On September 18, 2025, the Issuer effected a 1-for-20 reverse stock split. The share counts herein reflect the reverse stock split.; On December 5, 2025, the Issuer's Compensation Committee of the Board of Directors approved the cancellation of the previously awarded grant of 694,137 restricted stock units, which was reported in a Form 4 filed on July 10, 2025.

View the original Form 4 on SEC EDGAR